The European Commission has kept Brazil off the list of countries authorized to export meat to the European market [1].
This decision creates a significant trade barrier for one of the world's largest meat producers. The exclusion threatens Brazilian agricultural revenue and highlights a growing rift between South American production methods and European regulatory demands.
According to the regulatory update published June 5, 2024 [1], the European Union maintained its veto because Brazil does not meet new requirements regarding the use of antimicrobials in animal production [1]. The Commission said these standards are necessary to protect public health and combat antimicrobial resistance [2].
Brazilian officials from the Ministry of Agriculture in São Paulo have engaged in dialogues with the EU to address the veto [2]. The dispute centers on the specific protocols used in livestock management, and the chemicals permitted during the growth cycle of animals intended for export.
While Brazil seeks to regain its standing in the European market, the EU continues to prioritize the implementation of these health safeguards [1]. The bloc's current stance indicates that diplomatic dialogue alone will not suffice without concrete changes to Brazilian animal husbandry practices [2].
The European Commission continues to review the compliance of various trading partners to ensure all imports align with the updated health directives [1]. Brazil remains the primary focus of these discussions due to the volume of its meat industry and its historical trade relationship with Brussels [2].
“The EU maintained its veto on Brazilian meat, keeping Brazil off the list of countries authorized to export meat.”
This regulatory standoff reflects a broader trend of the European Union leveraging its market access to enforce global health and environmental standards. By barring Brazilian meat over antimicrobial use, the EU is pushing for a global shift away from certain livestock farming practices. For Brazil, this necessitates a systemic overhaul of its agricultural production to remain competitive in high-value markets, as the EU is unlikely to waive health requirements for political or economic expediency.
